Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1G-CSF1件: Filgrastim1件: Filgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬18件: 2, 6, 11, 13, 16, 22, 47, 49, 51, 60, 61, 62, 65, 85, 96, 284, 285, 331 💬
2G04be03----1件: 86 💬
3G04be08----1件: 86 💬
4G04cb02----1件: 2 💬
5G1117337----2件: 67, 299 💬
6G1567970----3件: 46, 53, 97 💬
7G1XCG----1件: 65 💬
8G1xcgd transduced CD34+ cells----1件: 65 💬
9G2019S LRRK2----1件: 6 💬
10G321605----3件: 85, 96, 97 💬
11G451990----2件: 51, 85 💬
12G914167----1件: 299 💬
13G957389----1件: 299 💬
14GA 20 MG/ML----1件: 13 💬
15GA 40 MG/ML----1件: 13 💬
16GA depot----1件: 13 💬
17GA depot 25MG once monthly----1件: 13 💬
18GA depot 40 MG----1件: 13 💬
19GA depot 40MG once monthly----1件: 13 💬
20GA depot 80 MG----1件: 13 💬
21GA-68-DOTA-NOC----1件: 84 💬
22GA-GCB1件: Velaglucerase alfa1件: Velaglucerase alfa 💬 1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
23Gaba blood level1件: gamma-Aminobutyric acid1件: gamma-Aminobutyric acid 💬 18件: GABBR,
GABBR,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬 		11件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬1件: 140 💬
24Gabapentin1件: Gabapentin1件: Gabapentin 💬 5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬 		10件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬4件: 6, 13, 19, 70 💬
25Gabapentin (neurontin® capsule 300MG) treatment1件: Gabapentin1件: Gabapentin 💬 5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬 		10件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 70 💬
26Gabapentin prescriptions1件: Gabapentin1件: Gabapentin 💬 5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬 		10件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 298 💬
27Gabapentina kern pharma1件: Gabapentin1件: Gabapentin 💬 5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬 		10件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 6 💬
28Gabapentine1件: Gabapentin1件: Gabapentin 💬 5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬 		10件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 13 💬
29Gabapentine 300MG1件: Gabapentin1件: Gabapentin 💬 5件: CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4,
SLC6A1 💬 		10件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Neuroactive ligand signaling, Oxytocin signaling pathway, Synaptic vesicle cycle 💬1件: 13 💬
30Gaboxadol1件: Gaboxadol1件: Gaboxadol 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬 		8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬2件: 201, 206 💬
31Gaboxadol monohydrate 0.5 MG1件: Gaboxadol1件: Gaboxadol 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬 		8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
32Gaboxadol monohydrate 0.5 MG capsule1件: Gaboxadol1件: Gaboxadol 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬 		8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
33Gaboxadol monohydrate 2 MG1件: Gaboxadol1件: Gaboxadol 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬 		8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
34Gaboxadol monohydrate 2 MG capsule1件: Gaboxadol1件: Gaboxadol 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬 		8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
35Gaboxadol monohydrate 5 MG1件: Gaboxadol1件: Gaboxadol 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬 		8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 201 💬
36GAD-7----1件: 299 💬
37Gadobenate dimeglumine1件: Gadobenic acid2件: Gadobenate dimeglumine ,
Gadobenic acid 💬 		--1件: 13 💬
38Gadobutrol1件: Gadobutrol1件: Gadobutrol 💬 --4件: 13, 22, 46, 226 💬
39Gadodiamide1件: Gadodiamide2件: Gadodiamide hydrate ,
Gadodiamide 💬 		--1件: 305 💬
40Gadolinium1件: Gadolinium---4件: 46, 77, 86, 305 💬
41Gadolinium contrast1件: Gadolinium---1件: 34 💬
42Gadolinium FOR abdomen1件: Gadolinium---1件: 65 💬
43Gadolinium FOR lower back1件: Gadolinium---1件: 65 💬
44Gadolinium-based contrast1件: Gadolinium---1件: 13 💬
45Gadopentetate dimeglumine1件: Gadopentetic acid2件: Gadopentetate dimeglumine ,
Gadopentetic acid 💬 		--2件: 13, 34 💬
46Gadoteric acid1件: Gadoteric acid2件: Gadoterate meglumine ,
Gadoteric acid 💬 		--2件: 13, 58 💬
47Gadoteridol1件: Gadoteridol1件: Gadoteridol 💬 --1件: 13 💬
48Gadovist 1 mmol/ML solucióN inyectable EN jeringa precargada/ cartucho precargado----1件: 13 💬
49Gadovist 1.0 mmol/ML injektionslösung1件: Gadobutrol1件: Gadobutrol 💬 --1件: 13 💬
50Gait analysis----1件: 149 💬
51Gait and balance----1件: 6 💬
52Gait and balance group training----1件: 6 💬
53Gait and balance training----1件: 6 💬
54Gait and balance training program----1件: 6 💬
55Galactose1件: Galactose1件: Galactose 💬 --2件: 171, 222 💬
56Galafold1件: Migalastat2件: Migalastat hydrochloride ,
Migalastat 💬 		1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
57Galantamine1件: Galantamine2件: Galantamine hydrobromide ,
Galantamine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬2件: 6, 11 💬
58Galantamine hydrobromide1件: Galantamine2件: Galantamine hydrobromide ,
Galantamine 💬 		1件: ACHE 💬 3件: Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬2件: 6, 127 💬
59Galcanezumab1件: Galcanezumab1件: Galcanezumab 💬 1件: CALC 💬 3件: Hormone signaling, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬1件: 226 💬
60Galen----1件: 162 💬
61Galen® tablet----2件: 43, 44 💬
62Galicaftor1件: Galicaftor1件: Galicaftor 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
63Gallium nitrate1件: Gallium nitrate1件: Gallium nitrate 💬 --1件: 299 💬
64Gallium-68 dotatate----1件: 84 💬
65Gallium-68-DOTA-N-octreotide----1件: 84 💬
66Gallium68-DOTA-NOC----1件: 85 💬
67Galsulfase1件: Galsulfase1件: Galsulfase 💬 1件: ARSB 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
68Gamma globulin----2件: 15, 50 💬
69Gamma interferon----1件: 18 💬
70Gamma knife radiosurgery----1件: 77 💬
71Gamma-linolenic acid1件: Gamolenic acid1件: Gamolenic acid 💬 --1件: 46 💬
72Gamma-secretase/notch signalling pathway inhibitor RO4929097----1件: 74 💬
73Gamma-tocopherol1件: gamma-Tocopherol---1件: 13 💬
74Gammagard liquid----1件: 65 💬
75Gammaglobulin----1件: 65 💬
76Gammanorm----2件: 14, 65 💬
77Gammanorm 165 MG/ML----1件: 65 💬
78Gammaplex1件: Human immunoglobulin G1件: Globulin, immune 💬 --2件: 63, 65 💬
79Gammaplex 101件: Human immunoglobulin G1件: Globulin, immune 💬 --1件: 65 💬
80Gammaplex, intravenous immunoglobulin----1件: 63 💬
81Gamunex-C----1件: 65 💬
82Ganaxalone----1件: 158 💬
83Ganaxolone1件: Ganaxolone1件: Ganaxolone 💬 16件: GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRA,
GABRB,
GABRB,
GABRB,
GABRD,
GABRE,
GABRG,
GABRG,
GABRG,
GABRP,
GABRQ 💬 		8件: GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬4件: 145, 152, 158, 206 💬
84Ganciclovir1件: Ganciclovir2件: Ganciclovir ,
Ganciclovir sodium 💬 		--3件: 28, 60, 97 💬
85Gandouling----1件: 171 💬
86Ganoderma----1件: 6 💬
87Garadacimab1件: Garadacimab1件: Garadacimab 💬 1件: F12 💬 1件: Complement and coagulation cascades 💬1件: 65 💬
88Gardasil----1件: 49 💬
89Gardasil vaccine----1件: 97 💬
90Garetosmab1件: Garetosmab1件: Garetosmab 💬 --1件: 272 💬
91Gastro-resistant phosphatidylcholine granules----1件: 97 💬
92Gastrointestinal quality OF life index----1件: 98 💬
93Gastroscopy----1件: 97 💬
94Gastrus----1件: 66 💬
95Gated MRI scan----1件: 75 💬
96Gazyvaro1件: Obinutuzumab1件: Obinutuzumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬2件: 49, 222 💬
97Gazyvaro - 1000 MG - concentrato PER soluzione PER infusione - USO endovenoso - flaconcino - 1000MG/40ML - 1 flaconcino----1件: 222 💬
98GB-0998----1件: 50 💬
99GB002----1件: 86 💬
100GB002 capsules----1件: 86 💬
101GB004----1件: 97 💬
102GB004-HCL----1件: 97 💬
103GB0139----1件: 85 💬
104GB224 10MG----1件: 46 💬
105GB224 15MG----1件: 46 💬
106GB224 20MG----1件: 46 💬
107GB224 2MG----1件: 46 💬
108GB224 30MG----1件: 46 💬
109GB224 5MG----1件: 46 💬
110GB242----1件: 46 💬
111GB261----1件: 49 💬
112GBP----1件: 13 💬
113GBT440----1件: 85 💬
114GBT440 300 MG capsule----1件: 85 💬
115GBT440 300 MG tablet----1件: 85 💬
116GC+HCQ----1件: 49 💬
117GC012F injection----2件: 11, 49 💬
118GC10081件: Fresolimumab1件: Fresolimumab 💬 3件: TGFB1,
TGFB2,
TGFB3 💬 		36件: AGE-RAGE signaling pathway in diabetic complications, Amoebiasis, Cell cycle, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Dilated cardiomyopathy, Efferocytosis, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Intestinal immune network for IgA production, Leishmaniasis, MAPK signaling pathway, Malaria, MicroRNAs in cancer, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, TGF-beta signaling pathway, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬2件: 85, 222 💬
119GC101----1件: 3 💬
120GC101 adeno-associated virus injection----1件: 3 💬
121GC1111_0.5MG/KG----1件: 19 💬
122GC1111_1.0MG/KG----1件: 19 💬
123GC1119----1件: 19 💬
124GC1123----1件: 19 💬
125GC1130A----1件: 19 💬
126GC301----1件: 256 💬
127GCB-001----1件: 3 💬
128GCB-002----1件: 156 💬
129GCK 100 MG----1件: 46 💬
130GCK 200 MG----1件: 46 💬
131GCK 300 MG----1件: 46 💬
132Gcsf----1件: 65 💬
133GDC-01341件: GDC-0134---1件: 2 💬
134GDC-0853----3件: 13, 46, 49 💬
135GDC-0853 RO7010939----3件: 13, 46, 49 💬
136GDC-6988----1件: 299 💬
137Gdnf & synchro MED infusion system----1件: 5 💬
138GE180 PET scan----1件: 6 💬
139GED-0301----2件: 96, 97 💬
140GED-0507-34-levo1件: GED-0507-34-Levo---1件: 97 💬
141GED-0507-34-levo 160 MG1件: GED-0507-34-Levo---1件: 97 💬
142GED-0507-34-levo 80 MG1件: GED-0507-34-Levo---1件: 97 💬
143GED0507----1件: 97 💬
144Gefapixant1件: Gefapixant2件: Gefapixant ,
Gefapixant citrate 💬 		1件: P2RX3 💬 4件: Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction 💬2件: 85, 226 💬
145Gefitinib1件: Gefitinib1件: Gefitinib 💬 1件: EGFR 💬 47件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Virion - Hepatitis viruses 💬1件: 75 💬
146Gefurulimab1件: Gefurulimab1件: Gefurulimab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 11 💬
147Gelatin1件: Gelatin2件: Gelatin ,
Donkey glue 💬 		--3件: 47, 62, 70 💬
148Gelatine1件: Gelatin2件: Gelatin ,
Donkey glue 💬 		--2件: 19, 296 💬
149Geleli----1件: 46 💬
150Gemcabene1件: Gemcabene---1件: 79 💬
151Gemfibrozil1件: Gemfibrozil1件: Gemfibrozil 💬 1件: NR1C1 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬2件: 6, 13 💬
152GEN6050X intravenous injection----1件: 113 💬
153Genakumab----1件: 107 💬
154Gene activated A-galactosidase A----1件: 19 💬
155Gene activated human glucocerebrosidase----1件: 19 💬
156Gene activated human glucocerebrosidase, velaglucerase alfa1件: Velaglucerase alfa1件: Velaglucerase alfa 💬 1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
157Gene analysis----1件: 79 💬
158Gene expressions OF mirna----1件: 46 💬
159Gene therapy----1件: 19 💬
160Gene therapy method FOR CGD----1件: 65 💬
161Gene therapy product-MCO-010----2件: 90, 301 💬
162Gene therapy product:VMCO-I----1件: 90 💬
163Gene therapy-VMCO-010----1件: 301 💬
164GENE-activated human glucocerebrosidase----1件: 19 💬
165GENE-activated human glucocerebrosidase 200U/vial----1件: 19 💬
166GENE-activated human glucocerebrosidase 400U/vial----1件: 19 💬
167GENE-modified autologous fibroblasts----1件: 36 💬
168GENE-modified autologous stem cells----1件: 285 💬
169GENE-transduced autologous CD34+ stem cells----1件: 65 💬
170General and neurological examination----1件: 19 💬
171General anesthesia----1件: 6 💬
172General anesthesia with tourniquet----1件: 46 💬
173General anesthesia without tourniquet----1件: 46 💬
174General corticotherapy----1件: 35 💬
175General population----2件: 46, 271 💬
176Generation OF induced pluripotent stem cells (ipsc) from fibroblasts obtained BY skin biopsy----1件: 102 💬
177Generation OF ipscs----1件: 21 💬
178Generic DRY powder inhaler----1件: 86 💬
179Genetic analyses----1件: 19 💬
180Genetic analysis----7件: 34, 85, 90, 93, 94, 96, 234 💬
181Genetic analysis BY sanger and whole exome next generation sequencing----1件: 84 💬
182Genetic analysis OF NLRP3----1件: 106 💬
183Genetic characterization----1件: 113 💬
184Genetic diagnosis----1件: 335 💬
185Genetic HMI-203----1件: 19 💬
186Genetic polymorphisms----1件: 67 💬
187Genetic profiling OF ALL eligible patients----1件: 278 💬
188Genetic sequencing----3件: 40, 231, 298 💬
189Genetic test: ACE polymorphism----3件: 3, 15, 256 💬
190Genetic test: ACTN3 polymorphism----3件: 3, 15, 256 💬
191Genetic testing OF THE alkaline phosphatase gene----1件: 172 💬
192Genetically engineered biological drugs, janus-kinase inhibitors, tumor necrosis factor inhibitors----1件: 46 💬
193Genetically engineered hematopoietic stem progenitor cells----1件: 285 💬
194Genetically engineered hematopoietic stem/progenitor cells----1件: 285 💬
195Genetically modified autologous blood stem cells----1件: 65 💬
196Genicular nerve block----1件: 107 💬
197Genistein1件: Genistein1件: Genistein 💬 --1件: 299 💬
198Genistein aglycone1件: Genistein1件: Genistein 💬 --1件: 19 💬
199Genisteine plus 150 MG CPL formaat 1 18,7 X 6,4 MM 438 MG----1件: 299 💬
200Genome-wide DNA methylation----1件: 96 💬
201Genomic DNA----1件: 97 💬
202Genomic sequencing----1件: 58 💬
203Genotonorm----1件: 193 💬
204Genotonorm miniquick 0,2 MG----1件: 193 💬
205Genotropin1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬5件: 13, 77, 107, 187, 193 💬
206Genotropin 12MG1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬3件: 74, 75, 78 💬
207Genotropin 5.3MG1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬3件: 74, 75, 78 💬
208Genotropin goquick1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 193 💬
209Genotropin miniquick----1件: 78 💬
210Genotropin miniquick 0.2MG1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬3件: 74, 75, 78 💬
211Genotropin miniquick 0.4MG1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬3件: 74, 75, 78 💬
212Genotropin miniquick 0.6MG1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬3件: 74, 75, 78 💬
213Genotropin miniquick 0.8MG1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬3件: 74, 75, 78 💬
214Genotropin miniquick 1.0MG1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬3件: 74, 75, 78 💬
215Genotropin miniquick 1.2MG1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬3件: 74, 75, 78 💬
216Genotype analysis FOR VDR RS1544410, RS2228570, RS731236, and RS7975232 polymorphisms----1件: 11 💬
217Genotype detection----1件: 49 💬
218Genoxal----1件: 222 💬
219Gensci048----2件: 46, 51 💬
220Gentamicin1件: Gentamicin2件: Gentamicin sulfate ,
Gentamicin 💬 		--3件: 36, 113, 299 💬
221Gentamicin infusions twice A week FOR SIX months1件: Gentamicin2件: Gentamicin sulfate ,
Gentamicin 💬 		--1件: 113 💬
222Gentamicin sulfate1件: Gentamicin2件: Gentamicin sulfate ,
Gentamicin 💬 		--1件: 36 💬
223Gentamicin sulfate 0.1% ointment1件: Gentamicin2件: Gentamicin sulfate ,
Gentamicin 💬 		--1件: 36 💬
224Gentamicin sulfate, injectable1件: Gentamicin2件: Gentamicin sulfate ,
Gentamicin 💬 		--1件: 36 💬
225Gentle jogger----1件: 21 💬
226GENZ-112638----1件: 19 💬
227GENZ-682452-AA----1件: 19 💬
228GENZ-682452-AU----3件: 6, 19, 67 💬
229Gereic DRY powder inhaler----1件: 86 💬
230Gerilimzumab----1件: 46 💬
231Gernebcin 80 MG----1件: 299 💬
232Gevokizumab1件: Gevokizumab1件: Gevokizumab 💬 1件: IL1B 💬 43件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬4件: 41, 50, 56, 269 💬
233Gevokizumab OPEN-label1件: Gevokizumab1件: Gevokizumab 💬 1件: IL1B 💬 43件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬1件: 269 💬
234GFB-887----1件: 222 💬
235GFI 38518168-AEK-B-007----1件: 46 💬
236GFT505----2件: 93, 94 💬
237GH pause----1件: 78 💬
238GH substitution----1件: 78 💬
239GHR-LRX----1件: 77 💬
240Ghrelin1件: Lenomorelin---3件: 6, 78, 299 💬
241GI-270384----1件: 97 💬
242Gilenya1件: Fingolimod3件: Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬3件: 2, 13, 14 💬
243Gilenya - 0.25 MG - capsule rigide - USO orale1件: Fingolimod3件: Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
244Gilenya - 0.5 MG - capsule rigide - USO orale1件: Fingolimod3件: Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
245Gilenya - 0.5 MG - capsule rigide - USO orale - blister divisibile PER dose unitaria(PVC/pvdc/ALU) scatola DA 7x1 capsule1件: Fingolimod3件: Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
246Gilenya - 0.5 MG - capsule rigide - USO orale - blister(PVC/pvdc/ALU) scatola DA 28 capsule1件: Fingolimod3件: Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
247Gilenya 0,5 MG Cápsulas duras1件: Fingolimod3件: Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 14 💬
248Gilenya 0,5 MG hartkapseln1件: Fingolimod3件: Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
249Gilenya 0,5MG CPS DUR1件: Fingolimod3件: Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
250Gilenya hard capsules1件: Fingolimod3件: Fingolimod hydrochloride ,
Fingolimod ,
Fingolimod lauryl sulfate 💬 		1件: S1PR1 💬 4件: Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬1件: 13 💬
251Gileyna----1件: 13 💬
252GILT-rhgaa1件: Reveglucosidase alfa---1件: 256 💬
253Ginger1件: Ginger1件: Ginger 💬 --2件: 46, 271 💬
254Ginkgo biloba1件: Ginkgo biloba1件: Ginkgo 💬 --3件: 13, 18, 47 💬
255Ginkgo biloba pills SIG: 300MG/TID1件: Ginkgo biloba1件: Ginkgo 💬 --1件: 90 💬
256Ginseng1件: Ginseng1件: Ginseng 💬 --2件: 13, 46 💬
257Ginsenoside1件: Ginsenosides---1件: 46 💬
258GIP----1件: 299 💬
259Giving DHA-rich supplement----1件: 299 💬
260Givinostat1件: Givinostat1件: Givinostat 💬 11件: HDAC10,
HDAC11,
HDAC1_2,
HDAC1_2,
HDAC3,
HDAC4_5,
HDAC4_5,
HDAC6,
HDAC7,
HDAC8,
HDAC9 💬 		20件: ATP-dependent chromatin remodeling, Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Polycomb repressive complex, TGF-beta signaling pathway, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis 💬2件: 107, 113 💬
261Givinostat hydrochloride - cohort 21件: Givinostat1件: Givinostat 💬 11件: HDAC10,
HDAC11,
HDAC1_2,
HDAC1_2,
HDAC3,
HDAC4_5,
HDAC4_5,
HDAC6,
HDAC7,
HDAC8,
HDAC9 💬 		20件: ATP-dependent chromatin remodeling, Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Polycomb repressive complex, TGF-beta signaling pathway, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis 💬1件: 113 💬
262Givosiran1件: Givosiran2件: Givosiran ,
Givosiran sodium 💬 		1件: E2.3.1.37 💬 2件: Glycine, serine and threonine metabolism, Porphyrin metabolism 💬1件: 254 💬
263GKT137831----2件: 85, 93 💬
264GL-07191件: GL-0719---1件: 61 💬
265GL701----1件: 49 💬
266GLA gene----1件: 19 💬
267Glargine----1件: 299 💬
268Glargine insulin----1件: 299 💬
269Glassia----1件: 231 💬
270Glatiramer acetate1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬 		32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬3件: 13, 96, 156 💬
271Glatiramer acetate (GA) 40 MG1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬 		32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
272Glatiramer acetate 150MG enteric coated tablets1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬 		32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
273Glatiramer acetate 150MG enteric-coated (gastro-resistant) tablets1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬 		32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
274Glatiramer acetate 20 MG1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬 		32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
275Glatiramer acetate 20 MG, with mitoxantrone1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬 		32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
276Glatiramer acetate 20 MG/0.5 ML1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬 		32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
277Glatiramer acetate 40 MG1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬 		32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
278Glatiramer acetate injection with oral cetirizine hydrochloride1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬 		32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
279Glatiramer acetate with minocycline1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬 		32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
280Glatiramer acetate, IFN-beta 1A (IM), IFN-beta 1A (subcutaneous), and IFN-beta 1B1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬 		32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
281Glatiramer acetate, interferons (intramuscular, subcutaneous, pegylated) teriflunomide, fumarates (dimethyl, diroximel, monomethyl) fingolimod, siponimod, ozanimod, ponesimod1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬 		32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
282Glatiramer acetate, N-acetylcysteine1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬 		32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
283Glatiramer acetato1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬 		32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
284Glatiramero acetato----1件: 13 💬
285Gleevec----1件: 34 💬
286Glial cell LINE-derived neurotrophic factor----1件: 6 💬
287Glicerol-1,3-didecanoato-2-octadeca-(6Z,9Z,12Z)-trienoato----1件: 13 💬
288Gliolan----1件: 96 💬
289Glivec1件: Imatinib2件: Imatinib mesylate ,
Imatinib 💬 		3件: ABL1,
KIT,
PDGFRA 💬 		31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬2件: 51, 86 💬
290Glivec 100 MG comprimidos recubiertos CON PELícula1件: Imatinib2件: Imatinib mesylate ,
Imatinib 💬 		3件: ABL1,
KIT,
PDGFRA 💬 		31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬2件: 34, 86 💬
291Glivec 100 MG filmtabletten1件: Imatinib2件: Imatinib mesylate ,
Imatinib 💬 		3件: ABL1,
KIT,
PDGFRA 💬 		31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬2件: 51, 86 💬
292Glivec 100 MG hartkapsel1件: Imatinib2件: Imatinib mesylate ,
Imatinib 💬 		3件: ABL1,
KIT,
PDGFRA 💬 		31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 86 💬
293Glivec 400 MG comprimidos recubiertos CON PELícula1件: Imatinib2件: Imatinib mesylate ,
Imatinib 💬 		3件: ABL1,
KIT,
PDGFRA 💬 		31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 34 💬
294Glivec® 100 MG filmtabletten1件: Imatinib2件: Imatinib mesylate ,
Imatinib 💬 		3件: ABL1,
KIT,
PDGFRA 💬 		31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬1件: 86 💬
295Global DNA methylation will BE quantified IN THE DNA samples BY colorimetry----1件: 63 💬
296Globifer forte----1件: 97 💬
297GLP-1----1件: 299 💬
298GLP1-RA (exenatide) administration----2件: 72, 78 💬
299GLPG0259----1件: 46 💬
300GLPG0259 oral capsule----1件: 46 💬
301GLPG0634----4件: 46, 96, 97, 271 💬
302GLPG0974----1件: 97 💬
303GLPG1205----3件: 85, 96, 97 💬
304GLPG1690----2件: 51, 85 💬
305GLPG1690 600 MG QD----1件: 85 💬
306GLPG1837----1件: 299 💬
307GLPG1837 dose 1----1件: 299 💬
308GLPG1837 dose 2----1件: 299 💬
309GLPG1837 dose 3----1件: 299 💬
310GLPG2222----1件: 299 💬
311GLPG2222 100 MG----1件: 299 💬
312GLPG2222 200 MG----1件: 299 💬
313GLPG2222 400 MG----1件: 299 💬
314GLPG2222 50 MG----1件: 299 💬
315GLPG2451 dose regimen A----1件: 299 💬
316GLPG2451 dose regimen B----1件: 299 💬
317GLPG2737----2件: 67, 299 💬
318GLPG2737 single dose----1件: 299 💬
319GLPG3067----1件: 299 💬
320GLPG3067 single dose----1件: 299 💬
321GLPG3667----2件: 49, 50 💬
322GLPG3970----3件: 46, 53, 97 💬
323GLPG3970 FILM-coated tablet----1件: 49 💬
324Glucagon1件: Glucagon2件: Glucagon ,
Glucagon hydrochloride 💬 		1件: GCGR 💬 3件: Glucagon signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 96 💬
325Glucocerebrosidase----1件: 19 💬
326Glucocerebrosidase umano GENE-attivato----1件: 19 💬
327Glucocorticoid----6件: 46, 49, 66, 113, 220, 228 💬
328Glucocorticoid + cytoxan----1件: 222 💬
329Glucocorticoid + tacrolimus----1件: 222 💬
330Glucocorticoid agent----1件: 46 💬
331Glucocorticoid combined with cyclophosphamide induction + maintenance----1件: 222 💬
332Glucocorticoid treatment----1件: 41 💬
333Glucocorticoids----10件: 35, 40, 41, 43, 44, 75, 96, 221, 222, 300 💬
334Glucocorticoids - reduced dose----2件: 43, 44 💬
335Glucocorticoids - standard dose----2件: 43, 44 💬
336Gluconato ferrico sodico----1件: 97 💬
337Glucorticoid taper regimen----1件: 40 💬
338Glucose1件: Dextrose, unspecified form2件: Dextrose ,
Glucose, liquid 💬 		--9件: 6, 13, 66, 77, 96, 97, 226, 254, 299 💬
339Glucose intake1件: Dextrose, unspecified form2件: Dextrose ,
Glucose, liquid 💬 		--1件: 257 💬
340Glucose profile FOR 2 weeks1件: Dextrose, unspecified form2件: Dextrose ,
Glucose, liquid 💬 		--1件: 299 💬
341Glucose solution AT A dose OF 1.75 G/KG (UP TO A maximum OF 75 G) FOR THE ogtt and glucose solution AT A dose OF 0.5 G/KG (UP TO A maximum OF 35 G) WAS injected IN 2.5-3 MIN FOR THE igtt1件: Dextrose, unspecified form2件: Dextrose ,
Glucose, liquid 💬 		--1件: 299 💬
342Glucose tablet1件: Dextrose, unspecified form2件: Dextrose ,
Glucose, liquid 💬 		--1件: 50 💬
343Glucose-based sports drink1件: Dextrose, unspecified form2件: Dextrose ,
Glucose, liquid 💬 		--1件: 97 💬
344Glucosidase alfa----1件: 256 💬
345Glucoside1件: Beta-D-Glucose1件: Glucose 💬 --1件: 46 💬
346Glucotrace----1件: 46 💬
347GLUT1 DS----1件: 248 💬
348Glutamate and aspartate----1件: 13 💬
349Glutamine1件: L-Glutamine1件: Glutamine 💬 --10件: 87, 89, 96, 97, 113, 214, 215, 222, 245, 299 💬
350Glutamine oral supplement1件: L-Glutamine1件: Glutamine 💬 --1件: 21 💬
351Glutamine oral supplementation1件: L-Glutamine1件: Glutamine 💬 --1件: 21 💬
352Glutathione1件: Glutathione2件: Glutathione ,
Oxiglutatione 💬 		--2件: 6, 299 💬
353Glutathione sodium1件: Glutathione2件: Glutathione ,
Oxiglutatione 💬 		--1件: 299 💬
354Gluten free diet----1件: 97 💬
355Gluten-free diet----2件: 94, 97 💬
356GLWL-01----1件: 193 💬
357Glycan----1件: 96 💬
358Glycerine GEL1件: Glycerin1件: Glycerin 💬 --1件: 265 💬
359Glycerol1件: Glycerin1件: Glycerin 💬 --1件: 79 💬
360Glycerol phenylbutyrate2件: Glycerin,
Glycerol phenylbutyrate		2件: Glycerin ,
Glycerol phenylbutyrate 💬 		--2件: 6, 7 💬
361Glycerol tributyrate1件: Glycerin1件: Glycerin 💬 --2件: 21, 302 💬
362Glycerol-1,3-didecanoate-2-octadeca-(6Z,9Z,12Z)-trienoate1件: Glycerin1件: Glycerin 💬 --1件: 13 💬
363Glycerol/saline1件: Glycerin1件: Glycerin 💬 --3件: 316, 317, 344 💬
364Glyceryl triacetate1件: Triacetin1件: Triacetin 💬 --1件: 307 💬
365Glyceryl trierucate1件: Glyceryl Trierucate---1件: 20 💬
366Glyceryl trierucate/glyceryl trioleate1件: Glyceryl Trierucate---1件: 20 💬
367Glyceryl trioleate1件: Glyceryl Trioleate---1件: 20 💬
368Glycine1件: Glycine1件: Glycine 💬 --6件: 35, 60, 226, 247, 299, 340 💬
369Glycine buffer1件: Glycine1件: Glycine 💬 --1件: 299 💬
370Glycomacropeptide-based protein substitute----1件: 240 💬
371Glycopyrrolate1件: Glycopyrronium3件: Glycopyrrolate ,
Glycopyrronium ,
Glycopyrronium tosylate 💬 		5件: CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬 		14件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬2件: 6, 34 💬
372Glycosade----3件: 65, 256, 257 💬
373Glycosbio nutritional supplement----1件: 299 💬
374Glycyrrhetinic acid----1件: 63 💬
375Glycyrrhiza1件: Glycyrrhiza glabra---2件: 53, 63 💬
376Glycyrrhiza glabra root1件: Glycyrrhiza glabra---1件: 97 💬
377Glycyrrhizin1件: Glycyrrhizic acid2件: Glycyrrhizin ,
Dipotassium glycyrrhizinate 💬 		1件: HSD11B1 💬 3件: Chemical carcinogenesis - DNA adducts, Metabolism of xenobiotics by cytochrome P450, Steroid hormone biosynthesis 💬2件: 46, 51 💬
378Glycyrrhizin and boswellic acid1件: Glycyrrhizic acid2件: Glycyrrhizin ,
Dipotassium glycyrrhizinate 💬 		1件: HSD11B1 💬 3件: Chemical carcinogenesis - DNA adducts, Metabolism of xenobiotics by cytochrome P450, Steroid hormone biosynthesis 💬1件: 46 💬
379Glytactin----1件: 240 💬
380GM-CSF----3件: 51, 60, 229 💬
381GM-CSF, fosfomycin and metronidazole----1件: 97 💬
382GM1 ganglioside----1件: 6 💬
383GM6041件: Alirinetide---1件: 2 💬
384GM6081件: Alirinetide---1件: 6 💬
385GMA161----1件: 63 💬
386GMA301 injection----1件: 86 💬
387GMP compliant-BM-MSC derived sevs----1件: 90 💬
388GMP intervention product----1件: 240 💬
389Gnbac1----1件: 13 💬
390Gnbac1 monoclonal antibody----1件: 13 💬
391GNC-038----2件: 46, 49 💬
392GNR-038, 100 ??/ KG----1件: 65 💬
393GNR-038, 100 ??/KG----1件: 65 💬
394GNR-038, 25 ??/KG----1件: 65 💬
395GNR-038, 50 ??/ KG----1件: 65 💬
396GNR-038, 50 ??/KG----1件: 65 💬
397GNR-055----1件: 19 💬
398GNR-055 1.0-2.0-3.0 MG/KG----1件: 19 💬
399GNR-055 2.0 MG/KG----1件: 19 💬
400GNR-055 3.0 MG/KG----1件: 19 💬
401GNR-069----1件: 63 💬
402GNR-086----1件: 54 💬
403Gnrh1件: Gonadorelin3件: Gonadorelin hydrochloride ,
Gonadorelin acetate ,
Gonadorelin 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
404Gnrh agonist1件: Gonadorelin3件: Gonadorelin hydrochloride ,
Gonadorelin acetate ,
Gonadorelin 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
405GNT0004----1件: 113 💬
406GNT0006----1件: 113 💬
407Gocovri----1件: 6 💬
408GOL----1件: 46 💬
409Gold nanocrystals1件: Gold---3件: 2, 6, 13 💬
410Gold standard questionnaire1件: Gold---1件: 291 💬
411Goldic serum----1件: 70 💬
412Golexanolone1件: Golexanolone---1件: 93 💬
413Golimumab1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬8件: 46, 56, 84, 96, 97, 107, 270, 271 💬
414Golimumab 1 MG PER KG1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
415Golimumab 100 MG1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 97 💬
416Golimumab 100 MG injections1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
417Golimumab 2 MG PER KG1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
418Golimumab 2 MG/KG IV1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
419Golimumab 200 MG1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
420Golimumab 4 MG PER KG1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
421Golimumab 400 MG1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
422Golimumab 50 MG1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 97 💬
423Golimumab 50 MG IN patients <80 KG and golimumab 100 MG IN patients >80 KG1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
424Golimumab 50 MG injections1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
425Golimumab 50 MG SC1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
426Golimumab dose 11件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
427Golimumab dose 21件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
428Golimumab injection1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 271 💬
429Golimumab intravenous1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
430Golimumab liquid IN prefilled PEN1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
431Golimumab liquid IN prefilled PEN or prefilled syringe1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
432Golimumab liquid IN prefilled syringe1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬4件: 46, 84, 97, 107 💬
433Golimumab liquid IN vial1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬3件: 46, 97, 271 💬
434Golimumab PRE-filled syringe1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 271 💬
435Golimumab prefilled PEN1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
436Golimumab prefilled PEN or prefilled syringe1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
437Golimumab prefilled syringe1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
438Golimumab trough levels1件: Golimumab1件: Golimumab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
439Golodirsen1件: Golodirsen1件: Golodirsen 💬 1件: DMD 💬 5件: Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬1件: 113 💬
440Gonadorelin acetate and triptorelin acetate2件: Gonadorelin,
Triptorelin		6件: Gonadorelin hydrochloride ,
Gonadorelin acetate ,
Triptorelin ,
Triptorelin pamoate ,
Gonadorelin ,
Triptorelin acetate 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
441Gonadotropin-releasing hormone1件: Gonadorelin3件: Gonadorelin hydrochloride ,
Gonadorelin acetate ,
Gonadorelin 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 76 💬
442Goserelin1件: Goserelin2件: Goserelin acetate ,
Goserelin 💬 		1件: GNRHR 💬 3件: GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬1件: 1 💬
443GP2013----1件: 46 💬
444GP2013 - A proposed biosimilar rituximab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 46 💬
445GP2015----1件: 46 💬
446GP2017----2件: 46, 271 💬
447GP91 grans----1件: 65 💬
448GPI 1485----1件: 6 💬
449GR181413----1件: 19 💬
450GR181413A----1件: 19 💬
451GR181413A/AT1001 capsule----1件: 19 💬
452GR181413A/AT1001 solution----1件: 19 💬
453GR3027----1件: 93 💬
454Graft intracerebral OF foetal neurons----1件: 8 💬
455Graft-versus-tumor induction therapy----2件: 60, 285 💬
456Gralise----2件: 97, 226 💬
457Granocyte----1件: 18 💬
458Granocyte 34----1件: 97 💬
459Granulated mesalamine----1件: 97 💬
460Granulocyte colony stimulating factor----6件: 2, 28, 36, 57, 65, 85 💬
461Granulocyte colony-stimulating factor----2件: 60, 296 💬
462Granulocyte-colony stimulating factor (G-CSF) and prednisone----1件: 13 💬
463Granulokine----1件: 51 💬
464Grape seed extracts1件: Grape---1件: 97 💬
465Grapefruit1件: Grapefruit---4件: 6, 46, 50, 97 💬
466Grapefruit juice1件: Grapefruit---1件: 83 💬
467GRC 4039----1件: 46 💬
468Green TEA1件: Green tea leaf1件: Green tea leaf 💬 --3件: 6, 28, 96 💬
469Green TEA group1件: Green tea leaf1件: Green tea leaf 💬 --1件: 46 💬
470Green TEA leaf1件: Green tea leaf1件: Green tea leaf 💬 --1件: 17 💬
471GRF6021----1件: 6 💬
472Group 1 OF patients will receive adalimumab while group 1 will receive ustekinumab----1件: 97 💬
473Group 1 or orencia treated group----1件: 46 💬
474Group 1- control diet----1件: 97 💬
475Group 2 ustekinumab 130 MG----2件: 96, 97 💬
476Group 2- UCD diet----1件: 97 💬
477Group 3: ustekinumab approximately 6 MG/KG----2件: 96, 97 💬
478Group A SLE prospective study----1件: 49 💬
479Group AD ANTI-PD + antidepressant----1件: 6 💬
480Group B SLE ONE blood donation----1件: 49 💬
481Group balance training----1件: 13 💬
482Group C meningococcal conjugate vaccine----1件: 14 💬
483Group exercise: community setting----1件: 70 💬
484Group R rasagiline----1件: 6 💬
485Group R+AD rasagiline + antidepressant----1件: 6 💬
486Growth hormone1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬16件: 2, 19, 46, 77, 78, 96, 97, 107, 113, 156, 191, 193, 195, 238, 265, 299 💬
487Growth hormone level and insulin like growth factor 11件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 36 💬
488Growth hormone receptor antagonist1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 77 💬
489Growth hormone releasing hormone1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 265 💬
490Growth hormone stimulation test1件: Somatotropin1件: Somatropin 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 299 💬
491GS-0151----1件: 46 💬
492GS-0272----1件: 46 💬
493GS-1427----1件: 97 💬
494GS-248----1件: 51 💬
495GS-4059----1件: 53 💬
496GS-4875----1件: 97 💬
497GS-4997 18 MG----1件: 86 💬
498GS-4997 2 MG----1件: 86 💬
499GS-4997 6 MG----1件: 86 💬
500GS-5718----1件: 46 💬
501GS-5737----1件: 299 💬
502GS-57451件: GS-5745---4件: 46, 96, 97, 299 💬
503GS-5745 IV1件: GS-5745---1件: 97 💬
504GS-5745 SC1件: GS-5745---1件: 97 💬
505GS-6034----4件: 46, 53, 96, 97 💬
506GS-6155 white 6 MG tablets----1件: 58 💬
507GS-6615 3 MG----1件: 58 💬
508GS-6615 3 MG pink----1件: 58 💬
509GS-6615 3 MG white----1件: 58 💬
510GS-6615 6 MG----1件: 58 💬
511GS-6615 6 MG white----1件: 58 💬
512GS-6615 pink 6 MG tablets----1件: 58 💬
513GS-6615 white 10 MG tablets----1件: 58 💬
514GS-6615 white 3 MG tablets----1件: 58 💬
515GS-66241件: Simtuzumab---2件: 85, 94 💬
516GS-9411----1件: 299 💬
517GS-9674----2件: 93, 94 💬
518GS-9674 100 MG----1件: 93 💬
519GS-9674 30 MG----1件: 93 💬
520GS-9876----2件: 46, 53 💬
521GS010----1件: 302 💬
522GS030-DP1件: GS030-DP---1件: 90 💬
523Gsgc----1件: 113 💬
524GSH----1件: 299 💬
525GSK 3196165----1件: 46 💬
526GSK1070806----2件: 56, 96 💬
527GSK1223249----2件: 2, 13 💬
528GSK1265744B (sodium salt) containing 14C-GSK1265744B----1件: 265 💬
529GSK1325760----2件: 86, 88 💬
530GSK1325760A----1件: 86 💬
531GSK1399686----1件: 97 💬
532GSK1550188----4件: 11, 49, 66, 222 💬
533GSK1550188 1MG/KG or 10MG/KG----1件: 49 💬
534GSK1550188 IV----1件: 49 💬
535GSK1550188 SC----1件: 49 💬
536GSK1605786----2件: 96, 97 💬
537GSK1605786 500 MG----1件: 96 💬
538GSK1605786 capsule----1件: 96 💬
539GSK1605786 chemocentryx: formulation A----1件: 96 💬
540GSK1605786 GSK direct-fill: formulation C----1件: 96 💬
541GSK1605786 GSK modified-process: formulation D----1件: 96 💬
542GSK1605786 GSK tablet: formulation E----1件: 96 💬
543GSK1605786 GSK: formulation B----1件: 96 💬
544GSK1605786A----2件: 96, 97 💬
545GSK1827771----1件: 46 💬
546GSK1841157----3件: 13, 35, 46 💬
547GSK2018682----1件: 13 💬
548GSK2018682 CD2 capsule----1件: 13 💬
549GSK2018682 CD3 micronised tablet----1件: 13 💬
550GSK2018682 CD3 NON-micronised tablet IN FED state----1件: 13 💬
551GSK2126458----1件: 85 💬
552GSK22560981件: GSK2256098---1件: 86 💬
553GSK2315698----1件: 28 💬
554GSK2330672----1件: 93 💬
555GSK2330672/linerixibat 40 MG1件: Linerixibat1件: Linerixibat 💬 1件: SLC10A2 💬 1件: Bile secretion 💬1件: 93 💬
556GSK2330811----2件: 51, 96 💬
557GSK2330811 solution FOR injection, 100MG/ML----1件: 51 💬
558GSK239512----1件: 13 💬
559GSK2395612----1件: 13 💬
560GSK2398852----1件: 28 💬
561GSK2402968----1件: 113 💬
562GSK2402968 3MG/KG/week----1件: 113 💬
563GSK2402968 6 MG/KG/week----1件: 113 💬
564GSK2402968 6MG/KG/week----1件: 113 💬
565GSK2586184----1件: 49 💬
566GSK2586184 100 MG----1件: 49 💬
567GSK2586184 200 MG----1件: 49 💬
568GSK2586184 400 MG----1件: 49 💬
569GSK2586184 400MG----1件: 97 💬
570GSK2586184 50 MG----1件: 49 💬
571GSK2586184 800MG single and repeat dose----1件: 49 💬
572GSK2586184 NEW formulation----1件: 49 💬
573GSK2586184 single dose taken with food----1件: 49 💬
574GSK2586184 single dose taken without food----1件: 49 💬
575GSK2586184 standard formulation----1件: 49 💬
576GSK2586881----1件: 86 💬
577GSK2618960----1件: 53 💬
578GSK26346763: ([18F]-FBA-A20fmdv2) IV infusion----1件: 85 💬
579GSK2788723----1件: 19 💬
580GSK2831781----1件: 97 💬
581GSK2831781 - double blind phase----1件: 97 💬
582GSK2831781 - open label phase----1件: 97 💬
583GSK2857916----1件: 28 💬
584GSK2973327----1件: 41 💬
585GSK2982772----2件: 46, 97 💬
586GSK2982772 60 MG----1件: 46 💬
587GSK2982772A, where A denotes THE free base----2件: 46, 97 💬
588GSK3008348----1件: 85 💬
589GSK3008348 nebuliser solution----1件: 85 💬
590GSK3039294----1件: 28 💬
591GSK31173911件: GSK-3117391---1件: 46 💬
592GSK3152314A----1件: 46 💬
593GSK315234----1件: 46 💬
594GSK315234 injection 100MG/ML----1件: 46 💬
595GSK3196165----1件: 46 💬
596GSK3196165 dose 1----1件: 46 💬
597GSK3196165 dose 2----1件: 46 💬
598GSK3196165 dose 3----1件: 46 💬
599GSK3511294----2件: 44, 45 💬
600GSK356278----1件: 8 💬
601GSK3888130B----1件: 13 💬
602GSK3915393----1件: 85 💬
603GSK4347859----1件: 49 💬
604GSK4527363----1件: 49 💬
605GSK4771261----1件: 67 💬
606GSK706769----1件: 46 💬
607GSK962040----1件: 6 💬
608GT-02287----1件: 6 💬
609GT4P1件: Glycerol phenylbutyrate1件: Glycerol phenylbutyrate 💬 --1件: 251 💬
610GTA glyceryl triacetate1件: Triacetin1件: Triacetin 💬 --1件: 307 💬
611GTA: glyceryltriacetate----1件: 307 💬
612GTG003.08----1件: 65 💬
613GTR----1件: 13 💬
614GTR.ACE----1件: 13 💬
615GTX-1021件: GTX-102---1件: 201 💬
616GTX-102 high dose fast period 1 and period 21件: GTX-102---1件: 65 💬
617GTX-102 LOW dose fast period 1 and period 21件: GTX-102---1件: 65 💬
618GTX-102 medium dose fast period 1 and period 21件: GTX-102---1件: 65 💬
619GTX-102 medium dose slow period 1 and period 21件: GTX-102---1件: 65 💬
620Guaiazulene1件: Guaiazulen1件: 1,4-Dimethyl-7-isopropylazulene 💬 --1件: 97 💬
621Guana2015----1件: 2 💬
622Guanabenz1件: Guanabenz2件: Guanabenz acetate ,
Guanabenz 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 13 💬
623Guanabenz acetato1件: Guanabenz2件: Guanabenz acetate ,
Guanabenz 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 2 💬
624Guanfacine extended release1件: Guanfacine2件: Guanfacine hydrochloride ,
Guanfacine 💬 		1件: ADRA2A 💬 4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 193 💬
625GUM arabic1件: Acacia1件: Acacia 💬 --1件: 46 💬
626GUNA-anti interleukin 1----1件: 46 💬
627GUNA-antiinterleukin 1 alfa----1件: 46 💬
628GUNA-antiinterleukin 1 beta----1件: 46 💬
629GUNA-interleukin 10----1件: 46 💬
630GUNA-interleukin 4----1件: 46 💬
631Gusacitinib1件: Gusacitinib1件: Gusacitinib 💬 4件: JAK1,
JAK2,
JAK3,
SYK 💬 		48件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neutrophil extracellular trap formation, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 49 💬
632Guselkum----1件: 97 💬
633Guselkumab1件: Guselkumab1件: Guselkumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬6件: 37, 41, 96, 97, 161, 269 💬
634Guselkumab 100 MG1件: Guselkumab1件: Guselkumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 37 💬
635Guselkumab dose 11件: Guselkumab1件: Guselkumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬3件: 51, 96, 97 💬
636Guselkumab dose 21件: Guselkumab1件: Guselkumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬3件: 51, 96, 97 💬
637Guselkumab dose 31件: Guselkumab1件: Guselkumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬2件: 96, 97 💬
638Guselkumab dose 41件: Guselkumab1件: Guselkumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
639Guselkumab dose 51件: Guselkumab1件: Guselkumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 96 💬
640Guselkumab intravenous1件: Guselkumab1件: Guselkumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 97 💬
641Guselkumab subcutaneous1件: Guselkumab1件: Guselkumab 💬 1件: IL23A 💬 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬1件: 97 💬
642Gusperimus1件: Gusperimus2件: Gusperimus trihydrochloride ,
Gusperimus 💬 		--1件: 44 💬
643Gusperimus + glucocorticoids1件: Gusperimus2件: Gusperimus trihydrochloride ,
Gusperimus 💬 		--1件: 44 💬
644GUT microbial transplantation----1件: 97 💬
645GUT-directed budesonide and SOC----1件: 66 💬
646Gutron 2,5MG----1件: 58 💬
647Gutron 5MG----1件: 58 💬
648GV1001 0.56MG----1件: 5 💬
649GV1001 1.12MG----1件: 5 💬
650Gvhd prophylaxis----2件: 60, 65 💬
651GW-1000-02----1件: 13 💬
652GW274150----1件: 46 💬
653GW274150 tablets----1件: 46 💬
654GW406381----1件: 46 💬
655GW406381X----1件: 46 💬
656GW582892----1件: 144 💬
657GW856553----1件: 46 💬
658GWP42003----1件: 97 💬
659GWP42003-P----6件: 140, 143, 144, 145, 156, 158 💬
660GWP42003-P 10 MG/KG/DAY dose----1件: 140 💬
661GWP42003-P 20 MG/KG/DAY dose----2件: 140, 144 💬
662GWP42003-P 5 MG/KG/DAY dose----1件: 140 💬
663GX 623----1件: 135 💬
664GX CJ7----1件: 135 💬
665Gylenia----1件: 13 💬
666Gylenia 0,5 MG----1件: 13 💬
667GYM3291件: GYM329---2件: 3, 113 💬
668GYPP-06 (GKT137831 free base), C10071301-D----1件: 93 💬
669GZ/SAR402671----2件: 19, 67 💬
670GZ385660----1件: 19 💬
671GZ402665----1件: 19 💬
672GZ402666----1件: 256 💬
673GZ402668----1件: 13 💬
674GZ402669----1件: 222 💬
675GZ402671----1件: 19 💬
676GZ402671 / SAR402671----1件: 19 💬
677GZ402673----1件: 13 💬
678GZ419829----1件: 256 💬